Correlation Between Sana Biotechnology and Repligen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Repligen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Repligen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and Repligen, you can compare the effects of market volatilities on Sana Biotechnology and Repligen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Repligen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Repligen.

Diversification Opportunities for Sana Biotechnology and Repligen

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Sana and Repligen is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Repligen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Repligen and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Repligen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Repligen has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Repligen go up and down completely randomly.

Pair Corralation between Sana Biotechnology and Repligen

Given the investment horizon of 90 days Sana Biotechnology is expected to under-perform the Repligen. In addition to that, Sana Biotechnology is 1.34 times more volatile than Repligen. It trades about -0.17 of its total potential returns per unit of risk. Repligen is currently generating about 0.02 per unit of volatility. If you would invest  15,035  in Repligen on August 30, 2024 and sell it today you would lose (36.00) from holding Repligen or give up 0.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sana Biotechnology  vs.  Repligen

 Performance 
       Timeline  
Sana Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sana Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Repligen 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Repligen are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical and fundamental indicators, Repligen is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Sana Biotechnology and Repligen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sana Biotechnology and Repligen

The main advantage of trading using opposite Sana Biotechnology and Repligen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Repligen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will offset losses from the drop in Repligen's long position.
The idea behind Sana Biotechnology and Repligen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas